Competition and Antitrust Law Enforcement Reform Act of 2025
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill defines congressional findings and purposes establishing that market power, concentration, and anticompetitive conduct are harmful to consumers, workers, small businesses, and democracy, and that strengthening antitrust, amends Clayton Act Section 7 to lower the standard for blocking mergers from 'substantially lessen competition' to 'appreciable risk of materially lessening competition', adds monopsony prohibition, creates presumptions, and requires companies that resolve antitrust merger proceedings to submit annual compliance reports for 5 years on pricing, quality, claimed efficiencies, and effectiveness of remedies, with certification under penalty. It relies on compliance mandates, definition changes, reporting requirements, and liability protections. The main policy areas are Antitrust, Technology, Finance, and Healthcare.
Who Benefits and How
Federal Trade Commission could gain revenue opportunities, Department of Justice Antitrust Division could gain revenue opportunities, and DOJ Antitrust Division could gain revenue opportunities.
Who Bears the Burden and How
Federal Trade Commission could face higher costs, Dominant firms with greater than 50% market share could face increased risk, and Large corporations pursuing mergers and acquisitions could face higher barriers.
Key Provisions
- Defines congressional findings and purposes establishing that market power, concentration, and anticompetitive conduct are harmful to consumers, workers, small businesses, and democracy, and that strengthening antitrust...
- Amends Clayton Act Section 7 to lower the standard for blocking mergers from 'substantially lessen competition' to 'appreciable risk of materially lessening competition', adds monopsony prohibition, creates presumptions...
- Requires companies that resolve antitrust merger proceedings to submit annual compliance reports for 5 years on pricing, quality, claimed efficiencies, and effectiveness of remedies, with certification under penalty...
- Directs FTC to study institutional investor common ownership of competitors in concentrated markets within 2 years, including impacts on competition and mechanisms by which institutional investors could affect...
- Directs GAO to study the success of merger remedies in consent decrees over the prior 8 years, including structural vs conduct remedies, and study the impact of M&A on wages, employment, innovation, and new business...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill defines congressional findings and purposes establishing that market power, concentration, and anticompetitive conduct are harmful to consumers, workers, small businesses, and democracy, and that strengthening antitrust, amends Clayton Act Section 7 to lower the standard for blocking mergers from 'substantially lessen competition' to 'appreciable risk of materially lessening competition', adds monopsony prohibition, creates presumptions, and requires companies that resolve antitrust merger proceedings to submit annual compliance reports for 5 years on pricing, quality, claimed efficiencies, and effectiveness of remedies, with certification under penalty.
Key Policy Areas
Antitrust, Technology, Finance, Healthcare
Primary Purpose
The bill defines congressional findings and purposes establishing that market power, concentration, and anticompetitive conduct are harmful to consumers, workers, small businesses, and democracy, and that strengthening antitrust, amends Clayton Act Section 7 to lower the standard for blocking mergers from 'substantially lessen competition' to 'appreciable risk of materially lessening competition', adds monopsony prohibition, creates presumptions, and requires companies that resolve antitrust merger proceedings to submit annual compliance reports for 5 years on pricing, quality, claimed efficiencies, and effectiveness of remedies, with certification under penalty.
Policy Domains
Sections 1-3: Title, Findings, and Definitions
Identified Gains
- Federal Trade Commission
- Department of Justice Antitrust Division
- DOJ Antitrust Division
- Whistleblowers with knowledge of criminal antitrust violations
- Employees, contractors, and agents who report antitrust violations
Identified Costs
- Federal Trade Commission
- Dominant firms with greater than 50% market share
- Large corporations pursuing mergers and acquisitions
- Dominant firms with greater than 50 percent market share
- Companies with over $100 billion in assets, sales, or market cap
Sponsors
Legislative Progress
In CommitteeMs. Klobuchar (for herself, Mr. Whitehouse, Mr. Blumenthal, Mr. Booker, …
Read twice and referred to the Committee on the Judiciary.
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Antitrust defendants who rely on market definition arguments, Companies engaged in exclusionary conduct, Companies engaged in exclusionary practices
Positive-direction: Employees who witness antitrust violations, Employees, contractors, and agents who report antitrust violations, Small and mid-size competitors, Smaller competitors foreclosed from markets, Whistleblowers with knowledge of criminal antitrust violations
Negative-direction: Antitrust defendants who rely on market definition arguments, Companies engaged in exclusionary conduct, Companies engaged in exclusionary practices, Companies engaged in price-fixing and cartel conduct, Companies engaging in price-fixing, bid-rigging, and market allocation, Companies required to make Hart-Scott-Rodino filings, Companies subject to FTC data requests under Section 6(b), Companies subject to antitrust enforcement, Companies subject to increased antitrust scrutiny, Companies that completed mergers with antitrust conditions, Companies with arbitration clauses, Dominant firms with greater than 50 percent market share, Employers who engage in retaliatory conduct, Employers who retaliate against whistleblowers, Large corporations pursuing mergers and acquisitions, Repeat antitrust offenders
DOJ Antitrust Division, Department of Justice Antitrust Division, Department of Justice and FTC enforcement
Federal Trade Commission faces effects in multiple directions
Positive-direction: DOJ Antitrust Division, Department of Justice Antitrust Division, Department of Justice and FTC enforcement, State attorneys general
Negative-direction: Department of Labor, Federal agencies with rules affecting competition, Government Accountability Office
Companies engaging in monopolization, Companies relying on arbitration clauses to avoid antitrust class actions, Dominant firms with greater than 50% market share
Antitrust enforcers and plaintiffs, Antitrust plaintiffs attorneys, Private antitrust plaintiffs
Corporate officers (CEO, CFO, General Counsel)
Companies with over $100 billion in assets, sales, or market cap
Companies in regulated industries claiming antitrust immunity
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → Federal Trade Commission
- "the_attorney_general"
- → Attorney General (DOJ Antitrust Division)
- "the_commission"
- → Federal Trade Commission
- "the_competition_advocate"
- → Competition Advocate (new FTC office)
- "the_assistant_attorney_general"
- → Assistant Attorney General (DOJ Antitrust Division)
- "the_commission"
- → Federal Trade Commission
- "the_comptroller_general"
- → Comptroller General (GAO)
- "the_chair"
- → Chair of the Federal Trade Commission
- "the_commission"
- → Federal Trade Commission
- "the_competition_advocate"
- → Competition Advocate (7-year term, reports to FTC Chair)
- "the_commission"
- → Federal Trade Commission
- "the_attorney_general"
- → Attorney General
- "the_commission"
- → Federal Trade Commission
- "the_attorney_general"
- → Attorney General
- "the_commission"
- → Federal Trade Commission
- "the_secretary"
- → Secretary of Labor
- "the_attorney_general"
- → Attorney General
- "the_commission"
- → Federal Trade Commission
- "antitrust_division"
- → Antitrust Division of DOJ
Note: The Secretary in Section 15 (whistleblower protections) refers specifically to the Secretary of Labor, not a generic Secretary.
Key Definitions
Terms defined in this bill
The meaning in 15 U.S.C. 12, plus section 5 of FTC Act (unfair methods of competition), plus this Act and its amendments.
The ability of a person, or group acting in concert, to profitably impose terms or conditions on counterparties (regarding price, quantity, quality, or other terms) that are more favorable than what could be obtained in a competitive market.
A dispute arising from an alleged violation of federal or state antitrust laws in which plaintiffs seek class certification under FRCP Rule 23 or comparable state law provision.
An employee, contractor, subcontractor, or agent of an employer.
Conduct that: (1) materially disadvantages one or more actual or potential competitors; or (2) tends to foreclose or limit the ability or incentive of actual or potential competitors to compete.
Section 1, 2, or 3 of the Sherman Act or section 5 of the FTC Act (unfair methods of competition).
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology